Recent insights in magnetic hyperthermia: From the "hot-spot" effect for local delivery to combined magneto-photo-thermia using magneto-plasmonic hybrids.
Combined therapy
Drug release
Local magnetic hyperthermia
Magnetic nanoparticles
Magneto-plasmonic nanosystems
Micro and nanogels
Molecularly imprinted polymers
Journal
Advanced drug delivery reviews
ISSN: 1872-8294
Titre abrégé: Adv Drug Deliv Rev
Pays: Netherlands
ID NLM: 8710523
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
received:
26
06
2018
revised:
21
09
2018
accepted:
31
10
2018
pubmed:
11
11
2018
medline:
25
2
2020
entrez:
11
11
2018
Statut:
ppublish
Résumé
Magnetic hyperthermia which exploits the heat generated by magnetic nanoparticles (MNPs) when exposed to an alternative magnetic field (AMF) is now in clinical trials for the treatment of cancers. However, this thermal therapy requires a high amount of MNPs in the tumor to be efficient. On the contrary the hot spot local effect refers to the use of specific temperature profile at the vicinity of nanoparticles for heating with minor to no long-range effect. This magneto-thermal effect can be exploited as a relevant external stimulus to temporally and spatially trigger drug release. In this review, we focus on recent advances in magnetic hyperthermia. Indirect experimental proofs of the local temperature increase are first discussed leading to a good estimation of the temperature at the surface (from 0.5 to 6 nm) of superparamagnetic NPs. Then we highlight recent studies illustrating the hot-spot effect for drug-release. Finally, we present another recent strategy to enhance the efficacity of thermal treatment by combining photothermal therapy with magnetic hyperthermia mediated by magneto-plasmonic nanoplatforms.
Identifiants
pubmed: 30414493
pii: S0169-409X(18)30284-9
doi: 10.1016/j.addr.2018.10.016
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-246Informations de copyright
Copyright © 2018. Published by Elsevier B.V.